Invesco NASDAQ Biotech UCITS ETF Acc - USD Share Price

ETF

SBIO

IE00BQ70R696

Market Closed - London S.E. 09:05:09 26/04/2024 pm IST 5-day change 1st Jan Change
42.46 USD +0.89% Intraday chart for Invesco NASDAQ Biotech UCITS ETF Acc - USD +0.56% -6.85%
Current month-7.72%
1 month-6.42%
Dynamic Chart

Investment objective

The Invesco NASDAQ Biotech UCITS ETF Acc aims to provide the performance of the NASDAQ Biotechnology Index, after fees. The index comprises biotechnology and pharmaceuticals companies (as defined by ICB) listed on the NASDAQ Stock Market. Stocks are filtered to meet minimum market capitalisation and liquidity requirements. They are then weighted by modified market capitalisation: the largest five constituents are capped at 8%; the remaining constituents are capped at 4%. The index is rebalanced quarterly and reviewed annually in December.
In partnership with
TrackInsight
Date Price Change Volume
26/24/26 42.46 +0.89% 6,266
25/24/25 42.08 -1.92% 15,690
24/24/24 42.9 -0.59% 2,634
23/24/23 43.16 +2.32% 11,530
22/24/22 42.18 +0.70% 13,996

Delayed Quote London S.E.

Last update April 26, 2024 at 09:05 pm IST

More quotes

ETF Ratings

Description

IE00BQ70R696
Total Expense Ratio 0.40%
Asset Class
Sector
Size
Currency
Provider
Underlying NASDAQ Biotechnology Total Return Index - USD

Features and characteristics

Jurisdiction
Replication Method
Replication Model
Date of creation
07/11/2014
Dividend Policy
Geographical Focus

Distribution

Retail investor

AuM evolution ( 27/03/2024 )

AuM (EUR) 595 M€
AuM 1M 606 M€
AuM 3 months 525 M€
AuM 6 months 527 M€
AuM 12 months 546 M€
  1. Stock Market
  2. ETF
  3. SBIO ETF